PRESS RELEASE published on 10/17/2023 at 14:00, 2 years 1 month ago Moolec Science Announces Capital Raise With Strategic Investors for ~US $30 Million
PRESS RELEASE published on 06/26/2023 at 14:30, 2 years 5 months ago Moolec Science Presents 'Piggy Sooy', a Soybean Platform That Can Produce Significantly High Amounts of Pork Proteins
PRESS RELEASE published on 05/30/2023 at 22:30, 2 years 6 months ago Moolec Science Presents Third Quarter FY 2023 Business Update
PRESS RELEASE published on 05/24/2023 at 22:00, 2 years 6 months ago Moolec Science to Host Third Quarter FY 2023 Business Update Call
PRESS RELEASE published on 04/18/2023 at 04:55, 2 years 7 months ago Moolec Science Secures Up to $50 Million in Committed Equity Financing With Nomura
PRESS RELEASE published on 04/11/2023 at 14:25, 2 years 7 months ago Moolec Science Acquires Food Ingredient Capabilities to Consolidate Molecular Farming Technology
PRESS RELEASE published on 04/05/2023 at 12:00, 2 years 7 months ago Moolec Science Achieves USDA-APHIS Regulatory Status Review Clearance for Molecular Farming Product
Published on 12/05/2025 at 02:35, 3 hours 20 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 4 hours 55 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 6 hours 50 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 6 hours 55 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 2 hours 24 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 6 hours 4 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 9 hours 29 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 9 hours 40 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 10 hours 44 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 11 hours 55 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 12 hours 10 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 12 hours 10 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 22 hours 54 minutes ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 11 hours ago Declaration of voting rights at the end of November 2025
